208
Views
2
CrossRef citations to date
0
Altmetric
Research Articles

In silico development of adenosine A2B receptor antagonists for sickle cell disease

, ORCID Icon, ORCID Icon & ORCID Icon
Pages 9592-9601 | Received 07 Sep 2020, Accepted 12 May 2021, Published online: 26 Jun 2021

References

  • Aldallal, S. M. (2020). Voxelotor: A ray of hope for sickle disease. Cureus, 12(2), e7105.
  • Altschul, S. F. (1997). Gapped BLAST and PSI-BLAST: A new generation of protein database search programs. Nucleic Acids Research, 25(17), 3389–3402. https://doi.org/10.1093/nar/25.17.3389
  • Araujo, M. D. (2019). Anemia falciforme complicada por crise vaso-oclusiva e síndrome torácica aguda. V UNIFACIG Scientific Seminar. Manhuaçu.
  • Ben, D. D. (2005). GPCRs as therapeutic targets: A view on adenosine receptors structure and functions, and molecular modeling support. Journal of the Iranian Chemical Society, 2(3), 176–188.
  • Benito, L. P. (2016). Application of molecular dynamics methods to the study of biological systems. Universitat Autònoma de Barcelona.
  • Brasil. (2015). Doença falciforme: Diretrizes básicas da linha de cuidado.
  • Britton, Z. T. (2012). An expression and purification system for the biosynthesis of adenosine receptor peptides for biophysical and structural characterization. Protein Expr Purif, 84(2), 224–235. https://doi.org/10.1016/j.pep.2012.06.005
  • Chandrasekaran, B., Samarneh, S., Jaber, A. M. Y., Kassab, G., & Agrawal, N. (2019). Therapeutic potentials of A2B adenosine receptor ligands: Current status and perspectives. Current Pharmaceutical Design, 25(25), 2741–2771. https://doi.org/10.2174/1381612825666190717105834
  • Conran, N., & Paula, E. V. (2020). Thromboinflammatory mechanisms in sickle cell disease – Challenging the hemostatic balance. Hematologica, 105(8), 1–11.
  • Felix, A. A., Souza, H. M., & Ribeiro, S. B. F. (2010). Aspectos epidemiológicos e sociais da doença falciforme. Revista Brasileira de Hematologia e Hemoterapia, 32(3), 203–208. https://doi.org/10.1590/S1516-84842010005000072
  • Field, J. J. (2014). The role of adenosine signaling in sickle cell therapeutics. Hematology/Oncology Clinics of North America, 28(2), 287–299.
  • Figueiredo, A. B. (2016). Recrutamento do receptor de adenosina A2B e ativação da via de AMPc-PI3K-ERK1/2 inibem a resposta de células dendríticas infectadas por Leishmania amazonensis Tese. Ouro Preto.
  • Gessi, S., Fogli, E., Sacchetto, V., Varani, K., Merighi, S., Leung, E., Lennan, S. M., & Borea, P. A. (2008). Thermodynamics of A2B adenosine receptor binding discriminates agonistic from antagonistic behavior. Biochemical Pharmacology, 75(2), 562–569. https://doi.org/10.1016/j.bcp.2007.09.003
  • Hauache, O. M. (2001). Receptores acoplados à proteína G: Implicações para a fisiologia e doenças endócrinas. Arquivos Brasileiros de Endocrinologia & Metabologia, 45(3), 228–239. https://doi.org/10.1590/S0004-27302001000300004
  • Hauser, A. S. (2017). Trends in GPCR drug discovery: New agents, targets and indications. Nature Reviews, 16, 829–842.
  • Hoelz, L. V. B., De Freitas, G. B. L., Torres, P. H. M., Fernandes, T. V. A., Albuquerque, M. G., Da Silva, J. F. M., Pascutti, P. G., & De Alencastro, R. B. (2013). Receptores Acoplados à Proteína G. Revista Virtual de Química, 5(5), 981–1000. https://doi.org/10.5935/1984-6835.20130071
  • Holtje, H. D., Sippl, W., Rognan, D., & Folkers, G. (1997). Molecular modeling: Basic principles and applications. John Wiley & Sons.
  • Jain, A. N., Cleves, A. E., Gao, Q., Wang, X., Liu, Y., Sherer, E. C., & Reibarkh, M. Y. (2019). Complex macrocycle exploration: Parallel, heuristic, and constraint-based conformer generation using ForceGen. JCAMD, 33(6), 531–558.
  • Jones, G., Willett, P., Glen, R. C., Leach, A. R., & Taylor, R. (1997). Development and validation of a genetic algorithm for flexible docking. Journal of Molecular Biology, 267(3), 727–748. https://doi.org/10.1006/jmbi.1996.0897
  • Kim, T., Jo, S., & Iyer, V. G. (2008). CHARMM-GUI: A web-based graphical user interface for CHARMM. Journal of Computational Chemistry, 29, 1859–1865.
  • Kumar, V., Meyer, D., & Lall, N. (2017). Comparative investigation of techniques used for mtr homology model refinement. Journal of poteomics & Bioinfrmatics, 10(11), 284–297.
  • Laskowski, R. A., MacArthur, M. W., Moss, D. S., & Thornton, J. M. (1993). PROCHECK: A program to check the stereochemical quality of protein structures. Journal of Applied Crystallography, 26(2), 283–291. https://doi.org/10.1107/S0021889892009944
  • Lang, P. T., Moustaka, D., Brozell, S., Carrasca, N., Mukherjee, S., Balius, T., Allen, W. J., Holden, P., Pegg, S., Raha, K., Shivakumar, D., Rizzo, R., Case, D., Shoiche, B., & Kuntz, I. (2017). DOCK 6.7 user’s manual. Regents of the University of California.
  • Levien, T. L., & Baker, D. E. (2020). Crizanlizumab. Hospital Pharmacy.
  • Manfredini, V., Castro, S., Wagner, S., & Benfato, M. S. (2007). A fisiopatologia da anemia falciforme. Infarma, 19(1), 3–6.
  • Martins, P. R. J., Moraes-Souza, H., & Silveira, T. B. (2010). Morbimortalidade em doença falciforme. Revista Brasileira de Hematologia e Hemoterapia, 32(5), 378–383. https://doi.org/10.1590/S1516-84842010000500010
  • Melo, F., Devos, D., Depiereux, E., & Feytmans, E. (1997). ANOLEA: A www server to assess protein structures. Proceedings. International Conference on Intelligent Systems for Molecular Biology, 5, 187–190.
  • Melo, T. R. F. (2012). Planejamento, Síntese e Avaliação Farmacológica de Novos Compostos Híbridos para o Tratamento dos Sintomas da Anemia Falciforme. Revista Virtual de Química, 3(6), 447–451.
  • Mokaberi, P., Babayan-Mashhadi, F., Zadeh, Z. A. T., Saberi, M. R., & Chamani, J. (2020). Analysis of the interaction behavior between Nano-Curcumin and two human serum proteins: Combining spectroscopy and molecular stimulation to understand protein-protein interaction. Journal of Biomolecular Structure and Dynamics, 1–20.
  • Muhammed, M. T., & Aki-Yalcin, E. (2018). Homology modeling in drug discovery: Overview, current applications, and future perspectives. Chemical Biology & Drug Design, 93(1), 12–20. https://doi.org/10.1111/cbdd.13388
  • Ortega-Gutiérrez, S. (2013). Avances en el estudio de receptores acoplados a proteínas G. An. Quím, 109(4), 276–284.
  • Paz, O. S. (2017). Nanomolar anti-sickling compounds identified by ligand-based pharmacophore approach. European Journal of Medicinal Chemistry, 136, 487–496. https://doi.org/10.1016/j.ejmech.2017.05.035
  • Pretto, L. A. (2017). Efetividade da hidroxiureia em pacientes com Anemia Falciforme. Monography. Universidade Estadual do Mato Grosso do Sul.
  • Salentin, S. (2015). PLIP: Fully automated protein-ligand interaction profiler. Nucl. Acids Res, 43(1), 443–447.
  • Santos Filho, O. A., & Alencastro, R. B. d. (2003). Modelagem de proteínas por homologia. Química Nova, 26(2), 253–259. https://doi.org/10.1590/S0100-40422003000200019
  • Schrödinger, L. L. C. (2016). PyMol: The PyMOL molecular graphics system, version 2.0. New York: Schrödinger LLC.
  • Souza, A. G. M. (2017). Prós e contras no uso da hidroxiuréia no tratamento da anemia falciforme. AC&T Científica.
  • Studer, G. (2017). Efficient algorithms in protein modelling [Dissertação]. Universität Basel.
  • UNIP ROT. (2014). UniProt: A hub for protein information. Nucleic Acids Research, 43(D1), D204–212.
  • Van der Spoel, D., Lindahl, E., Hess, B., Van Burren, A. R., Apol, E., Meulenhoff, P. J., Tieleman, D. P., Sijbers, A. L. T. M., Feenstra, K. A., Van Drunen, R., & Berendsen, H. J. C. (2005). GROMACS user manual version 5. (2), 1–298.
  • Verdonk, M. L., Cole, J. C., Hartshorn, M. J., Murray, C. W., & Taylor, R. D. (2003). Improved protein–ligand docking using GOLD. Proteins, 52, 609–623. https://doi.org/10.1002/prot.10465
  • Zoete, V., Cuendet, M. A., Grosdidier, A., & Michielin, O. (2011). SwissParam, a fast force field generation tool for small organic molecules. Journal of Computational Chemistry, 32(11), 2359–2368. https://doi.org/10.1002/jcc.21816
  • Whitehead, T. L. (2006). Molecular modeling: Basic principles and applications, second edition. Journal of Chemical Education, 28(6), 116–118.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.